US Patent 9993474 Bromocriptine formulations
Patent 9993474 was granted and assigned to Veroscience on June, 2018 by the United States Patent and Trademark Office.
All edits
Edits on 1 Feb, 2024
Golden AI
Edits made to:
Infobox (+1 properties)
Infobox
Patent Citations Received
Edits on 30 Jan, 2024
Golden AI
Edits made to:
Infobox (+1 properties)
Infobox
Patent Citations Received
Edits on 8 Dec, 2023
Golden AI
Edits made to:
Article (+256 characters)
Article
Patent abstract
The present application describes pharmaceutical formulations of bromocriptine mesylate and methods of manufacturing and using such formulations. The formulations are useful for improving glycemic control in the treatment of type 2 diabetes.
Edits on 1 Oct, 2023
Golden AI
Edits made to:
Infobox (+4 properties)
Infobox
Patent Inventor Names
Anthony H. Cincotta0
Craig Michael Bowe0
Laura Jean Weston0
Paul Clark Stearns0
Edits on 7 Jun, 2023
Golden AI
Edits made to:
Infobox (+1 properties)
Infobox
Patent Citations Received
Edits on 24 May, 2023
Golden AI
Edits made to:
Infobox (+1/-1 properties)
US Patent 09993474 Bromocriptine formulations US Patent 9993474 Bromocriptine formulations
Infobox
Patent Number
099934740
Patent Number
99934740
Edits on 26 Sep, 2022
Golden AI
Infobox
Is a
Patent Applicant
Current Assignee
Patent Jurisdiction
Patent Number
099934740
Date of Patent
June 12, 2018
0Patent Application Number
156180550
Date Filed
June 8, 2017
0Patent Primary Examiner
Edits on 20 Jan, 2022
Golden AI
Edits made to:
Infobox (+9 properties)
US Patent 09993474 Bromocriptine formulations
Infobox
Is a
Patent applicant
Current assignee
Patent jurisdiction
Patent number
09993474
Date of patent
June 12, 2018
Patent application number
15618055
Date Filed
June 8, 2017
Patent primary examiner
Find more entities like US Patent 9993474 Bromocriptine formulations
Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
